Hypertension 2020 Scientific Sessions

September 10–13, 2020
Now a virtual event!

Sponsored by: Council on Hypertension
Council on Kidney in Cardiovascular Disease

This is a three-day scientific program for clinical and basic researchers focusing on recent advances in hypertension research.

New for 2020

Update: Hypertension 2020 is Now a Virtual Event

Hypertension 2020 Scientific Session will take place as a virtual event on September 10–13, 2020. You can expect a similar amount of content as you would have experienced at the face to face conference, which will include our keynote lecture, oral abstract presentations, moderated poster sessions and e-poster sessions.

Please check back for the latest updates on the HTN 2020 virtual event. Please contact virtualevents@heart.org with any questions you may have.

Abstract Guidelines


IMPORTANT The Hypertension Scientific Sessions 2020 Abstract Submission deadline has been extended to June 15, 2020.
This year only, there will be no late-breaking submission period. Please be sure to submit your abstract in any category by June 15, 2020. See the Abstracts & Awards page for submission categories and guidelines.

IMPORTANT: The AHA has moved to a single sign-on process for submitting abstracts and disclosures through our website, Professional Heart Daily.

  • Abstract submitters must have a username and password on professional.heart.org to complete their abstract submission when submitting to any AHA scientific meeting.
     
  • If you do not remember your Professional Heart Daily login information or need to update your personal profile, do not create a new account. Please reach out to AHA Customer Service for assistance:

    AHA Customer Service
    (888) 242-2453 (Inside U.S.)
    (214) 570-5935 (Outside U.S.)
    Email: professional.help@heart.org
    Hours of Operation: Monday-Friday (8:00 a.m. – 5:00 p.m.) CT  
     
  • The AHA is now required to collect financial disclosures from all abstract submitting authors and co-authors.

    • As the submitting author, please be prepared to provide all co-author emails.
       
    • Co-authors without a complete disclosure will receive separate correspondence to submit this information.

Why You Should Attend #Hypertension20

Considered one of the most important medical meetings on this subject in the world, the conference includes oral and poster presentations selected from abstracts submitted by clinical and basic researchers, followed by discussions led by leading authorities. With experts in the fields of hypertension and its relationship to cardiac and kidney disease, stroke, obesity, and genetics, attendees will have the opportunity to connect with cross-disciplinary researchers from around the world.

This meeting also includes several interactive sessions specifically designed to benefit trainees and early career investigators, including a trainee poster session to highlight innovative research and how-to sessions that provide in-depth information about a range of topics related to the study of hypertension as well as The Clinical Practice Clinical Science Track focuses on applying clinical science to the clinician’s practice and the Primary Care Track is a "Meeting within a Meeting" dedicated to practical advice for the Primary Care Provider (PCP) interested in clinical hypertension.

2020 Key Dates

2020 Key Dates
DateEvent
Feb. 19, 2020Abstract & Awards Submission Open
April 15, 2020Registration opens
June 15, 2020NEW Abstract submission closes. There is NO Late-Breaking submission period in 2020.
July 7, 2020Early Bird Registration Deadline
July 8, 2020Advance Registration Begins
July 28, 2020Advance Registration Deadline
July 29, 2020Standard Registration begins
Sept. 10-13, 2020Hypertension Scientific Sessions - a virtual event

Accreditation


Watch this space closer to the conference for available CME/CE activities.

Disclosure Policy
All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.

BECOME A MEMBER

Join or renew your AHA/ASA Professional Membership today to save on registration for all AHA Scientific Sessions.

JOIN NOW
QUESTIONS?

E-mail: scientificconferences@heart.org
Phone: (888) 242-2453 or (214) 570-5935
Exhibit Information and Application
Julie Davis| (214) 706-1943